MedTrace Logo

Chinese Acute Ischemic Stroke Treatment Outcome Registry

NCT02470624 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2015-10-23

No results posted yet for this study

Summary

This is a multi-center registry study. The investigators will include 10,000 patients with confirmed acute ischemic stroke in China. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.

Conditions

Interventions

OTHER

treatment following current guideline

Sponsors & Collaborators

  • Techpool Bio-Pharma Co., Ltd.

    collaborator INDUSTRY

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Yining Huang, MD · Peking University First Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02470624 on ClinicalTrials.gov